Dirt Poor Country Provides HCV/Hepatitis C Patients Drugs

One tablet will cost Tk 600 in Bangladesh, and the aggregate expense of the treatment would be Tk 50,400 for a 12-week course contrasted with the whooping Tk 67 lakh in created nations. Singapore: Bangladesh medication major Beximco pharmaceuticals as of late reported the dispatch of the non specific variant of the miracle drug Sofosbuvir for treating hepatitis C under the brand name Sofovir C.

The medication considered as a shelter to hepatitis C patients was at first delivered by Gilead Sciences under its image Sovaldi. Touted as a standout amongst the most lavish pharmaceuticals, the medication costs $1,000 per tablet in the created business sector. The solution was initially dispatched in Bangladesh by nearby drugmaker, Incepta Pharmaceuticals.

"We are glad to have assumed a part in presenting this achievement treatment at a value which is right now the least on the planet. It will be sold as a remedy just pharmaceutical, and will be disseminated through our own dispersion channel and won't be accessible in retail outlets, " said, Mr Nazmul Hassan, overseeing executive of Beximco Pharma.

All inclusive, it is evaluated that 170-185 million individuals, around 3 percent of the world's populace, are chronically contaminated with hepatitis C infection. In Bangladesh, hepatitis C rises as a noteworthy wellbeing issue with about two million patients evaluated to be contaminated with this infection, Beximco said in the announcement.